Deerfield Management Company, L.P. (Series C) Pmv Pharmaceuticals, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $4,338 - $10,542	-470 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $7.75 Million - $12.3 Million	-521,530 Reduced 99.91%	470 $10,000
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $5.64 Million - $8.53 Million	-282,000 Reduced 35.07%	522,000 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $10.7 Million - $13.7 Million	380,320 Added 89.77%	804,000 $27.5 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $7.25 Million - $11.7 Million	236,488 Added 126.33%	423,680 $13.9 Million
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $4.37 Million - $8.44 Million	137,192 Added 274.38%	187,192 $11.5 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $1.78 Million - $1.9 Million	50,000 New	50,000 $1.78 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$10.4 Million
0.23% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.65M
Shares

$5.87 Million
0.08% of portfolio
Sio Capital Management, LLC New York, NY

3.21M
Shares

$5.17 Million
2.53% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$4.23 Million
0.43% of portfolio
Alkeon Capital Management LLC New York, NY

2.34M
Shares

$3.77 Million
0.01% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account